Bionor Pharma’s First Reboost Vacc-4x Study Accepted for Publication in the Vaccine Journal
(Oslo, Norway, 7 August 2013) Bionor Pharma ASA (OSE: BIONOR) announces that the results from the Company’s first re-boost clinical trial of Vacc-4x have been accepted for publication in the renowned journal Vaccine. The Phase II trial was conducted at Oslo University Hospital and completed in 2010. The trial investigated the effect of re-boosting 22 …